NCT04689542

Brief Summary

The use of personal protective equipment is mandatory for healthcare workers caring patient with COVID-19. To maximise the reduction of virus spread during clinical procedures involving the presence of healthcare workers, it is also recommended to patients to wear surgical facemask. Routine clinical procedures include cardio-pulmonary and strengthening exercises. During these exercises, the wearing of a face mask may be difficult to tolerate by patients, especially since they experience breathing difficulties due to the illness. Therefore, this study aims to verify the effects of the surgical facemask on breathing difficulties and exercise performance during a 1-minute sit to stand test.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started Jan 2021

Shorter than P25 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 2, 2021

Completed
Last Updated

November 8, 2021

Status Verified

November 1, 2021

Enrollment Period

3 months

First QC Date

December 29, 2020

Last Update Submit

November 5, 2021

Conditions

Keywords

Sit-To-Stand testSurgical FacemaskDyspnea

Outcome Measures

Primary Outcomes (1)

  • Changes in dyspnea level

    The Modified Borg dyspnea scale will be used to estimate dyspnea This scale range from 0 (no dyspnea) to 10 (maximal dyspnea)

    Before, immediately after and 2 minutes after the sit-to-stand test

Secondary Outcomes (4)

  • Changes in respiratory rate

    Before, immediately after and 2 minutes after the sit-to-stand test

  • Changes in heart rate

    Before, immediately after and 2 minutes after the sit-to-stand test

  • Changes in pulsed oxygen saturation (SpO2)

    Before, immediately after and 2 minutes after the sit-to-stand test

  • Number of sit-to-stand repetition

    1 minute

Study Arms (2)

Surgical Facemask

EXPERIMENTAL

The surgical facemask will be worn during the sit-to-stand test

Other: Sit-To-Stand test

Control

NO INTERVENTION

No facemask will be worn during the sit-to-stand test

Interventions

The 1-minute sit-to-stand test will be realized with or without a surgical facemask covering the face of the patient with COVID-19

Surgical Facemask

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalized for COVID-19
  • No need of supplemental oxygen during the procedure

You may not qualify if:

  • Altered state of consciousness
  • Respiratory co-morbidities
  • Neurological or orthopedic co-morbidities susceptible to alter the reliability of the sit-to-stand test
  • Having required high flow nasal cannula or non-invasive ventilation during the hospital stay

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cliniques universitaires Saint-Luc

Brussels, 1200, Belgium

Location

MeSH Terms

Conditions

COVID-19Dyspnea

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 29, 2020

First Posted

December 30, 2020

Study Start

January 1, 2021

Primary Completion

April 2, 2021

Study Completion

April 2, 2021

Last Updated

November 8, 2021

Record last verified: 2021-11

Locations